These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 19004038

  • 1. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah I, Chow SK, Goh EM.
    J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
    [Abstract] [Full Text] [Related]

  • 2. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW.
    J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
    [Abstract] [Full Text] [Related]

  • 3. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah S, Chow SK, Goh EM.
    Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
    [Abstract] [Full Text] [Related]

  • 4. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [Abstract] [Full Text] [Related]

  • 5. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH, Wu HX, Huang YL, Xue J, Yang XY, Zhu L, Wen LH.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 15; 88(27):1888-91. PubMed ID: 19040000
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.
    Nephrol Dial Transplant; 2009 May 15; 24(5):1472-7. PubMed ID: 19075192
    [Abstract] [Full Text] [Related]

  • 8. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 9. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S, Deesomchok U, Hiransuttikul N, Uaratanawong S.
    J Med Assoc Thai; 2004 Nov 30; 87(11):1374-9. PubMed ID: 15825716
    [Abstract] [Full Text] [Related]

  • 10. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
    Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Chadha AB, Ramsey-Goldman R.
    Rheumatology (Oxford); 2006 Jan 30; 45(1):53-60. PubMed ID: 16278288
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.
    Yeap SS, Othman AZ, Zain AA, Chan SP.
    Int J Rheum Dis; 2012 Feb 30; 15(1):17-24. PubMed ID: 22324943
    [Abstract] [Full Text] [Related]

  • 12. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
    Sambrook PN, Kotowicz M, Nash P, Styles CB, Naganathan V, Henderson-Briffa KN, Eisman JA, Nicholson GC.
    J Bone Miner Res; 2003 May 30; 18(5):919-24. PubMed ID: 12733733
    [Abstract] [Full Text] [Related]

  • 13. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD, Cheah SP, Taylor K, Ahern MJ.
    J Rheumatol; 2001 Mar 30; 28(3):566-70. PubMed ID: 11296960
    [Abstract] [Full Text] [Related]

  • 14. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, Melton M.
    Curr Med Res Opin; 2007 Jun 30; 23(6):1341-9. PubMed ID: 17594775
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M, Robeva R, Popivanov P.
    Clin Rheumatol; 2003 Oct 30; 22(4-5):318-23. PubMed ID: 14579164
    [Abstract] [Full Text] [Related]

  • 16. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
    Malavolta N, Zanardi M, Veronesi M, Ripamonti C, Gnudi S.
    Int J Tissue React; 1999 Oct 30; 21(2):51-9. PubMed ID: 10568224
    [Abstract] [Full Text] [Related]

  • 17. Prevention of bone loss in paraplegics over 2 years with alendronate.
    Zehnder Y, Risi S, Michel D, Knecht H, Perrelet R, Kraenzlin M, Zäch GA, Lippuner K.
    J Bone Miner Res; 2004 Jul 30; 19(7):1067-74. PubMed ID: 15176988
    [Abstract] [Full Text] [Related]

  • 18. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug 30; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 19. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT, Barr RD, Webber C, Guo CY, Wright M, Atkinson SA.
    J Oncol Pharm Pract; 2005 Jun 30; 11(2):51-6. PubMed ID: 16460605
    [Abstract] [Full Text] [Related]

  • 20. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, McIlwain HH, Freeman PG, Aranow C, Petri MA, Deodhar AA, Blanton E, Manzi S, Kavanaugh A, Lisse JR, Ramsey-Goldman R, McKay JD, Kivitz AJ, Mease PJ, Winkler AE, Kahl LE, Lee AH, Furie RA, Strand CV, Lou L, Ahmed M, Quarles B, Schwartz KE.
    J Rheumatol; 2008 Aug 30; 35(8):1567-75. PubMed ID: 18634158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.